In this episode, host Dr. Reni Butler speaks with Dr. Kalina Slavkova, Dr. Ruya Kang, Dr. Despina Kontos, and Dr. Habib Rahbar about their groundbreaking research using MRI-based radiomic features to improve risk stratification in ductal carcinoma in situ (DCIS). The discussion explores how combining clinical data, imaging, and AI-driven analysis could help personalize treatment and reduce overtreatment in breast cancer care.

MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial). Slavkova and Kang et al. Radiology 2025; 315(1):e241628.